Reference
1. Hooker AB, Lemmers M, Thurkow AL, et al. Systematic review and
meta-analysis of intrauterine adhesions after miscarriage: prevalence,
risk factors and long-term reproductive outcome. Hum Reprod
Update. 2014;20(2):262-278.
2. Johary J, Xue M, Zhu X, Xu D, Velu PP. Efficacy of estrogen therapy
in patients with intrauterine adhesions: systematic review. J
Minim Invasive Gynecol. 2014;21(1):44-54.
3. Bosteels J, Weyers S, Mol BW, D’Hooghe T. Anti-adhesion barrier gels
following operative hysteroscopy for treating female infertility: a
systematic review and meta-analysis. Gynecol Surg.2014;11:113-127.
4. Deans R, Abbott J. Review of intrauterine adhesions. J Minim
Invasive Gynecol. 2010;17(5):555-569.
5. Schenker JG, Margalioth EJ. Intrauterine adhesions: an updated
appraisal. Fertil Steril. 1982;37(5):593-610.
6. Schenker JG. Etiology of and therapeutic approach to synechia uteri.Eur J Obstet Gynecol Reprod Biol. 1996;65(1):109-113.
7. Asherman JG. Traumatic intra-uterine adhesions. J Obstet
Gynaecol Br Emp. 1950;57(6):892-896.
8. March CM. Management of Asherman’s syndrome. Reprod Biomed
Online. 2011;23(1):63-76.
9. Kou L, Jiang X, Xiao S, Zhao YZ, Yao Q, Chen R. Therapeutic options
and drug delivery strategies for the prevention of intrauterine
adhesions. J Control Release. 2020;318:25-37.
10. Thomson AJ, Abbott JA, Kingston A, Lenart M, Vancaillie TG.
Fluoroscopically guided synechiolysis for patients with Asherman’s
syndrome: menstrual and fertility outcomes. Fertil Steril.2007;87(2):405-410.
11. Hanstede MMF, van der Meij E, Veersema S, Emanuel MH. Live births
after Asherman syndrome treatment. Fertil Steril.2021;116(4):1181-1187.
12. Deans R, Vancaillie T, Ledger W, Liu J, Abbott JA. Live birth rate
and obstetric complications following the hysteroscopic management of
intrauterine adhesions including Asherman syndrome. Hum Reprod.2018;33(10):1847-1853.
13. Chen L, Zhang H, Wang Q, et al. Reproductive Outcomes in Patients
With Intrauterine Adhesions Following Hysteroscopic Adhesiolysis:
Experience From the Largest Women’s Hospital in China. J Minim
Invasive Gynecol. 2017;24(2):299-304.
14. Hooker AB, de Leeuw RA, Twisk JWR, Brolmann HAM, Huirne JAF.
Reproductive performance of women with and without intrauterine
adhesions following recurrent dilatation and curettage for miscarriage:
long-term follow-up of a randomized controlled trial. Hum Reprod.2021;36(1):70-81.
15. Hooker AB, Mansvelder FJ, Elbers RG, Frijmersum Z. Reproductive
outcomes in women with mild intrauterine adhesions; a systematic review
and meta-analysis. J Matern Fetal Neonatal Med. 2021:1-9.
16. Hanstede MM, van der Meij E, Goedemans L, Emanuel MH. Results of
centralized Asherman surgery, 2003-2013. Fertil Steril.2015;104(6):1561-1568 e1561.
17. Roy KK, Baruah J, Sharma JB, Kumar S, Kachawa G, Singh N.
Reproductive outcome following hysteroscopic adhesiolysis in patients
with infertility due to Asherman’s syndrome. Arch Gynecol Obstet.2010;281(2):355-361.
18. Valle RF, Sciarra JJ. Intrauterine adhesions: hysteroscopic
diagnosis, classification, treatment, and reproductive outcome. Am
J Obstet Gynecol. 1988;158(6 Pt 1):1459-1470.
19. Zikopoulos KA, Kolibianakis EM, Platteau P, et al. Live delivery
rates in subfertile women with Asherman’s syndrome after hysteroscopic
adhesiolysis using the resectoscope or the Versapoint system.Reprod Biomed Online. 2004;8(6):720-725.
20. Chen L, Xiao S, He S, Tian Q, Xue M. Factors That Impact Fertility
after Hysteroscopic Adhesiolysis for Intrauterine Adhesions and
Amenorrhea: A Retrospective Cohort Study. J Minim Invasive
Gynecol. 2020;27(1):54-59.
21. Morales B, Movilla P, Wang J, et al. Patient-reported menstrual and
obstetric outcomes following hysteroscopic adhesiolysis for Asherman
syndrome. F S Rep. 2021;2(1):118-125.
22. Feng Q, Gao B, Huang H, et al. Obstetrical outcome in the third
trimester after hysteroscopic adhesiolysis. Ann Transl Med.2020;8(4):51.
23. Zhang Y, Zhu X, Zhang T, Zhang Y, Zhang M, Lin X. Analysis of risk
factors for obstetric outcomes after hysteroscopic adhesiolysis for
Asherman syndrome: A retrospective cohort study. Int J Gynaecol
Obstet. 2022;156(1):89-94.
24. Zhang LP, Wang M, Shang X, et al. The incidence of placenta related
disease after the hysteroscopic adhesiolysis in patients with
intrauterine adhesions. Taiwan J Obstet Gynecol.2020;59(4):575-579.
25. Baradwan S, Baradwan A, Bashir M, Al-Jaroudi D. The birth weight in
pregnant women with Asherman syndrome compared to normal intrauterine
cavity: A case-control study. Medicine (Baltimore).2018;97(32):e11797.
26. International Association of D, Pregnancy Study Groups Consensus P,
Metzger BE, et al. International association of diabetes and pregnancy
study groups recommendations on the diagnosis and classification of
hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676-682.
27. Stepan H, Kuse-Fohl S, Klockenbusch W, et al. Diagnosis and
Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG
(S1-Level, AWMF Registry No. 015/018, December 2013). Geburtshilfe
Frauenheilkd. 2015;75(9):900-914.
28. Obstetrics Subgroup CSoO, Gynecology CMA. [Guidelines for
diagnosis and treatment of intrahepatic cholestasis of pregnancy
(2015)]. Zhonghua Fu Chan Ke Za Zhi. 2015;50(7):481-485.
29. Obstetrics Subgroup CSoO, Gynecology CMA, Obstetrics Subgroup
Chinese Society of O, Gynecology Chinese Medical A. [Guideline of
prevention and treatment about postpartum hemorrhage (2014)].Zhonghua Fu Chan Ke Za Zhi. 2014;49(9):641-646.
30. Quinn JA, Munoz FM, Gonik B, et al. Preterm birth: Case definition
& guidelines for data collection, analysis, and presentation of
immunisation safety data. Vaccine. 2016;34(49):6047-6056.
31. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and
causes of preterm birth. Lancet. 2008;371(9606):75-84.
32. American College of O, Gynecologists’ Committee on Practice B-O.
Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice
Bulletin, Number 234. Obstet Gynecol. 2021;138(2):e65-e90.
33. ACOG Practice Bulletin No.142: Cerclage for the management of
cervical insufficiency. Obstet Gynecol. 2014;123(2 Pt 1):372-379.
34. Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia:
Pathophysiology, Challenges, and Perspectives. Circ Res.2019;124(7):1094-1112.
35. Di Guardo F, Palumbo M. Asherman syndrome and insufficient
endometrial thickness: A hypothesis of integrated approach to restore
the endometrium. Med Hypotheses. 2020;134:109521.
36. Rabaglino MB, Post Uiterweer ED, Jeyabalan A, Hogge WA, Conrad KP.
Bioinformatics approach reveals evidence for impaired endometrial
maturation before and during early pregnancy in women who developed
preeclampsia. Hypertension. 2015;65(2):421-429.
37. Garrido-Gomez T, Dominguez F, Quinonero A, et al. Defective
decidualization during and after severe preeclampsia reveals a possible
maternal contribution to the etiology. Proc Natl Acad Sci U S A.2017;114(40):E8468-E8477.
38. Ng SW, Norwitz GA, Pavlicev M, Tilburgs T, Simon C, Norwitz ER.
Endometrial Decidualization: The Primary Driver of Pregnancy Health.Int J Mol Sci. 2020;21(11).
39. Silver RM, Branch DW. Placenta Accreta Spectrum. N Engl J
Med. 2018;378(16):1529-1536.
40. Khopkar U, Williams RM, Selinger M. Morbid adhesion of the placenta
after hysteroscopic lysis of intrauterine adhesions. Fertil
Steril. 2006;86(5):1513 e1511-1513.
41. Engelbrechtsen L, Langhoff-Roos J, Kjer JJ, Istre O. Placenta
accreta: adherent placenta due to Asherman syndrome. Clin Case
Rep. 2015;3(3):175-178.
42. Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta:
the role of decidua and extravillous trophoblast. Placenta.2008;29(7):639-645.
43. Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of
human fetal growth: the role of the mother, placenta, and fetus.Endocr Rev. 2006;27(2):141-169.
44. Carter AM. Evolution of placental function in mammals: the molecular
basis of gas and nutrient transfer, hormone secretion, and immune
responses. Physiol Rev. 2012;92(4):1543-1576.
45. Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for
preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic
vaginitis during the first trimester of pregnancy. BJOG.2009;116(10):1315-1324.
46. Manns-James L. Bacterial vaginosis and preterm birth. J
Midwifery Womens Health. 2011;56(6):575-583.
47. Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes
KK. Independent associations of bacterial vaginosis and Chlamydia
trachomatis infection with adverse pregnancy outcome. JAMA.1986;256(14):1899-1903.
48. Odibo AO, Talucci M, Berghella V. Prediction of preterm premature
rupture of membranes by transvaginal ultrasound features and risk
factors in a high-risk population. Ultrasound Obstet Gynecol.2002;20(3):245-251.
49. Liu Z, Kong Y, Gao Y, et al. Revealing the interaction between
intrauterine adhesion and vaginal microbiota using highthroughput
sequencing. Mol Med Rep. 2019;19(5):4167-4174.
50. Peebles K, Kiweewa FM, Palanee-Phillips T, et al. Elevated Risk of
Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A
Prospective Longitudinal Cohort Study. Clin Infect Dis.2021;73(3):513-520.
51. Merki-Feld GS, Lebeda E, Hogg B, Keller PJ. The incidence of
actinomyces-like organisms in Papanicolaou-stained smears of copper- and
levonorgestrel-releasing intrauterine devices. Contraception.2000;61(6):365-368.
52. Chen C, Zhang JW, Xia HW, et al. Preterm Birth in China Between 2015
and 2016. Am J Public Health. 2019;109(11):1597-1604.